Metri Bio has appointed Michele Keough as Chief Operating Officer, bringing more than two decades of experience building and scaling biotechnology organizations. Across leadership roles in research strategy, operations, and alliance management, Michele has helped guide complex therapeutic programs from early development through organizational growth.
Most recently, Michele served in senior leadership roles at Moderna, Atalanta Therapeutics, and Aura Biosciences, following a 15-year career at Genzyme. Her experience connecting scientific strategy with operational execution will be instrumental as Metri advances its human-relevant platform for endometriosis drug discovery, expands its biobank, and moves toward target nomination and compound screening.
